Table 2. Numerical data of viability, cell number, and proliferation.

*represents significant alteration as compared to K (control), non-treated sample (p‹0.05). g/f/mDNA: genomic/fragmented/hypermethylated deoxyribonucleic acid; ODN: CpG oligonucleotide; DISU: 4,4’Diisothiocyanatostilbene-2,2’-disulfonic acid; C: chloroquine; SD: standard deviation.

Sample	Alamar Blue (mean% ± SD)	Average cell number / 350 μl (±SD)	Proliferation% (± SD)
K	100 ± 1.1	800000 ± 8800	100 ± 1.1
O	120.17 ± 4.5*	760000 ± 32680	95 ± 4.3
D	111.41 ± 3.8	810000 ± 25920	101.25 ± 3.2
C	116.23 ± 2.9*	775000 ± 31775	96.87 ± 4.1
Kg	127.51 ± 3.1*	220000 ± 9900	27.5 ± 4.5*
Kf	112.61 ± 2.2	855000 ± 31635	106.87 ± 3.7
Km	147.87 ± 3.4*	720000 ± 19440	90 ± 2.7*
gO	139 ± 3.1*	270000 ± 3780	33.75 ± 1.4*
gD	134.44 ± 2.7*	310000 ± 6510	38.75 ± 2.1*
gC	123.55 ± 3.1*	230000 ± 4370	28.75 ± 1.9*
gOD	75.75 ± 2.6*	690000 ± 24840	86.25 ± 3.6*
gDC	90.99 ± 3.3	100000 ± 1600	12.5 ± 1.6*
fO	198,02 ± 4.7*	745000 ± 23840	93.12 ± 3.2
fD	120.87 ± 3.7*	665000 ± 21945	83.12 ± 3.3*
fC	121.18 ± 2.5*	560000 ± 13440	70 ± 2.4*
fOD	99.61 ± 2.3	730000 ± 26280	91.25 ± 3.6
fDC	107.62 ± 3.2	640000 ± 17920	80 ± 2.8*
mO	155.15 ± 4.1*	740000 ± 25160	92.5 ± 3.4
mD	141.85 ± 3.9*	875000 ± 36750	109.37 ± 4.2
mC	183.48 ± 4.6*	560000 ± 16240	70 ± 2.9*
mOD	90.12 ± 2.5	1140000 ± 60420	142.5 ± 5.3 *
mDC	92.34 ± 3.1	580000 ± 9860	72.5 ± 1.7*